SpermCheck in August gained additional retail distribution for its SpermCheck Fertility, an FDA-approved at-home screening test that determines with 98% accuracy whether a man has a normal or low sperm count. Infertility affects nearly 7 million U.S. couples every year.
Swiss Precision Diagnostics recently launched its Clearblue Advanced Pregnancy Test with Weeks Estimator — the first and only pregnancy test that also provides an estimate of time since ovulation for women testing pregnant — into the U.S. marketplace.
CPG manufacturers may have another reason to ensure their products can be advertised as "BPA-free." Exposure to BPA (Bisphenol-A) could be a contributing factor to why some couples are having difficulty conceiving, reported Catherine Racowsky, director of the Assisted Reproductive Technologies Laboratory at Brigham and Women's Hospital and author of the BPA study.
Procter & Gamble launched Clearblue Advanced Digital Ovulation Test, the only ovulation test that can identify a woman’s four best days to get pregnant, two more days than any other test on the market, according to the company.
E.p.t, creator of the original home pregnancy test, has partnered with the American Fertility Association to support the vast community of those who are actively trying to conceive during National Infertility Awareness Month this April.
The National Advertising Division on Thursday recommended that Church & Dwight discontinue its claim that the company’s First Response digital ovulation test is the “first and only test to predict ovulation based on your unique LH hormone level.”
A study slated to appear in the Journal of Clinical Endocrinology & Metabolism, a publication of the Endocrine Society, found that adolescent girls that take the diabetes drug metformin may prevent or delay the development of polycystic ovary syndrome, a common cause of infertility.